论文部分内容阅读
目的探讨妊娠合并子宫肌瘤患者在剖宫产术中同时行子宫肌瘤剔除术的安全性及可行性。方法选择2011年1—12月在剖宫产术中行子宫肌瘤剔除术的106例患者作为研究组,以同期妊娠无子宫肌瘤行单纯子宫下段剖宫产患者89例作为对照组,比较两组手术时间、术中及术后出血量、术后住院天数、并发症发生率、术中术后缩宫素用量、术后肛门排气时间及体温恢复时间。结果研究组与对照组比较,术后住院天数、术后缩宫素用量、肛门排气时间及体温恢复时间差异均无统计学意义(均P>0.05),但是研究组手术时间[(70±12)min]明显长于对照组[(50±8)min],术中出血量及术中缩宫素用量也均明显高于对照组,差异均有统计学意义(均P<0.05)。结论在无其他特殊情况下剖宫产术中行子宫肌瘤剔除术,并没有增加手术的风险,因此是安全可行的。
Objective To investigate the safety and feasibility of simultaneous myomectomy in cesarean section during pregnancy with uterine fibroids. Methods From January to December 2011, 106 patients undergoing cesarean myomectomy in cesarean section were selected as the study group. 89 pregnant women with no uterine fibroids underwent simple uterine myometrium in the same period of pregnancy were selected as control group, Group operation time, intraoperative and postoperative bleeding, postoperative hospital days, the incidence of complications, intraoperative and postoperative oxytocin consumption, postoperative anal exhaust time and body temperature recovery time. Results Compared with the control group, there was no significant difference in postoperative hospital stay, postoperative oxytocin consumption, anal exhaust time and body temperature recovery time (all P> 0.05), but the study group operation time [(70 ± 12 min) was significantly longer than that of the control group [(50 ± 8) min). The intraoperative blood loss and the amount of oxytocin in operation were also significantly higher than those in the control group (all P <0.05). Conclusion In the absence of other special cases of cesarean myomectomy myomectomy, and does not increase the risk of surgery, it is safe and feasible.